The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled. Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Banking and financial services for servicers and lenders
Represents servicers and lenders in post-origination loan modifications, loan assumptions, and loan defeasances. more
Real estate investment and development for an international hotel company
Represented an international hotel company in Houston, Texas in acquisition of adjacent parcel of land for expansion of existing hotel, significant more
Design/build agreements for correctional facilities
Drafted and negotiated design/build agreements on behalf of P.J. Dick Incorporated for the construction of three campus-style correctional facilities more
Trademark and unfair competition matters for WMS Gaming Inc.
Represents WMS Gaming Inc., a leader in the video gaming equipment industry, in trademark litigation before federal trial and appellate courts more